We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Hand Procedure for Removing Kidney

By HospiMedica staff writers
Posted on 23 Apr 2002
A minimally invasive procedure for removing a kidney is expected to increase live kidney donations by reducing hospital stay and recovery time and by reducing many of the fears associated with the surgery.

Aided by a laparoscopic camera, the procedure allows a surgeon to safely remove a kidney by inserting a hand into the abdomen through a small three-inch incision. More...
First, the donor's abdomen is inflated to provide ample room and a better view of the kidney and surrounding organs. Next, tubes are placed in the abdomen to provide access for the camera and instruments. Then the surgeon inserts a hand through a gel material into the abdomen, and the hand functions as a surgical tool to guide the laparoscopic devices used to remove the kidney.

The procedure, called GelPort HAL Nephrectomy, was pioneered by Applied Medical (Rancho Margarita, CA, USA), utilizing the GelPort Hand-Access device developed by the company. The company says donors experience less pain and scarring and need only a three-day hospital stay and 2-3 weeks for recovery. In contrast, open surgery results in a 10-12 inch incision, possible removal of a rib, and up to 10 weeks in recovery time.

"With this technique, you are able to insert your hand through a small three-inch incision that allows you to maintain your tactile sensation, palpate arteries, locate blood vessels, and use compression to achieve hemostasis if necessary,” said Dr. Joseph Del Pizzo, director of laparoscopic surgery at New York-Presbyterian Hospital (NY, USA). "You get all the benefits of open surgery without the large incision, and that's what benefits your patients.”




Related Links:
Applied Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.